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Introduction 
The intrauterine environment impacts on foetal growth and development. Any interference on 
the interactions among foetus, placenta and mother is closely linked to the risk of developing 
long-term neuronal disorders, metabolic and cardiovascular diseases in postnatal life (Li et 
al., 2012; Warner and Ozanne, 2010).  
Hypoxia, a condition in which the body experiences a loss of adequate oxygen, is one of the 
foetal stressing events capable of altering the brain development process and function, 
causing neurobehavioral, neuropsychological and neuropsychiatric disorders (Li et al., 2012). 
Traumatic birth, abruption of the placenta, umbilical cord compression, or failure of the 
neonate to successfully begin breathing are recognised as risk factors of the perinatal 
hypoxia-ischemia, which lead to Hypoxic Ischemic Encephalopathy (HIE) in 1 to 3 per 1000 
full term births (Graham et al., 2008; Logitharajah et al., 2009; McGuire, 2007). It has been 
reported that roughly 20-25% of affected newborns die during the postnatal period whilst 
25% of survivors with moderate HIE and 100% of survivors with severe HIE develop 
permanent neurologic injuries, including cerebral palsy, epilepsy, visual motor dysfunction 
and mental retardation (Douglas-Escobar and Weiss, 2015; Murray et al., 2016). When global 
perinatal hypoxia-ischemia occurs, dysfunctions can occur in multiple organs, including the 
gut (Nikiforou et al., 2016). Feeding intolerance, altered intestinal motility and necrotizing 
enterocolitis have been reported among the detrimental clinical effects affecting the gut of 
infants with perinatal hypoxia-ischemia (Berseth and McCoy, 1992; Fox and Godavitarne, 
2012; Neu and Walker, 2011). Hypothermia is the most studied and optimized therapeutic 
method (Akula et al., 2015; Edwards et al., 2010; Eicher et al., 2005; Gunn and Thoresen, 
2015; Gluckman et al., 2005; Schierholz, 2014; Thoresen et al., 2013) and has been 
incorporated in the Guidelines of International Consensus on Cardiopolmunary Resuscitation 
and Emergency Cardiovascular Care Science and in the recommendations of the American 
Heart Association in 2010 (Kattwinkel et al., 2010; Perlman et al., 2010). The hypothermic 
treatment involves reducing the body temperature of the infant within the first 6 hours 
(ideally within 3 hours) after ischemia in order to reduce the chance of detrimental effects, 
limiting cerebral damages, reducing the consumption of brain energy and reducing 
consumption of energy in the brain  (Jacobs et al., 2013; Thoresen et al., 2013). The 
esophageal temperature is reduced to either 34.5 ± 0.5°C if the head is cooled, or 33.5 ± 
0.5°C if the whole-body is cooled, and treatment is continued for 48–72 h (Jacobs et al., 
2013).  
The gut microbiota can be considered a dynamic organ of the human body, which 
continuously changes in composition and positively influences immunological and metabolic 
pathways, impacting the host health and wellness. Advances in research showed that the gut 
microbiota, as part of the gut-brain axis, can impact on host physiology and Central Nervous 
System performance including mood, cognition, other complex behaviours, and brain 
development (Forsythe et al, 2012; Stilling et al., 2014). At birth, development of the 
gastrointestinal microbiota in infants shifts towards a more adult-like status at two to three 
years of life (Costello et al., 2012; Relman, 2012). Many factors, e. g., gestational age, mode 
of delivery (spontaneous vaginal delivery or caesarean section), diet (breast milk or formula 
milk), sanitation, and antibiotic treatment (Adlerberth and Wold, 2009; Marques et al., 2010; 
Hill et al., 2017) influence the colonization process following delivery. Any dysregulation or 
alteration during this assembly process could contribute to adverse developmental 
programming and lifelong health outcomes. Both HIE and hypothermic therapeutic total body 
cooling (TBC) treatment represents disruptive events. The inflammatory process occurring 
during the first 24-48 hours post HI (Bona et al., 1999) and the low body temperature of 
infants exposed to TBC might influence the development and evolution of the gut microbiota, 
and its biological function. To our knowledge, the relation between hypothermia, biodiversity 
and metabolic function of the gut microbiota in infants who suffered perinatal HIE is 
unknown. The aim of this study was to investigate the impact of neuroprotection-induced 
hypothermia following birth on the evolution of gut microbiota in developing infants, and to 
describe the metabolomics profile of faecal samples in a group of full term infants with 
perinatal HIE. 
METHODS 
Patients and ethical approval 
This was an observational study associated with infants who had undergone TBC in the 
Neonatal Unit at Cork University Maternity Hospital at birth. Infants who have undergone 
TBC due to HIE were recruited at birth and faecal samples were collected at 2 years of age 
(n=9). Faecal samples collected from infants in the INFANTMET study at 2 years were used 
as a control group for this study (n=8) (Hill et el., 2017). Once obtained, faecal samples were 
stored at -20 ˚C. Ethical approval was obtained from the Cork University Hospitals Research 
Ethics Committee and informed consent was obtained from the parents of all subjects. Infant 
demographics including apgar scores, mode of birth, gestational age, antibiotic 
administration, feeding regimes and severity of HIE diagnosis (Dx) were recorded (table 1).  
Microbial DNA extraction and amplification 
Microbial DNA was extracted from 0.2 g faecal samples using the Repeat Bead Beating 
(RBB) method described by Yu and Morrison, with some modifications (see supplementary 
material) (Morrison et al., 2004). The V3-V4 regions of the 16S rRNA gene were amplified 
and adapter sequences chosen according to the 16S metagenomic sequencing library protocol 
for the Illumina MiSeq using the following 16S primer pair F –
(5'TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG) 
and R- 
(5'GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAAT
CC) (Klindworth et al., 2013). 
Bioinformatic Analysis  
300 bp paired-end reads were assembled using FLASH with parameters of a minimum 
overlap of 20 bp and a maximum overlap of 120 bp (Magoč et al., 2011). The QIIME suite of 
tools, v1.8.0, was used for further processing of paired-end reads, including quality filtering 
based on a quality score of  > 25 and removal of mismatched barcodes and sequences below 
length thresholds (Caporaso et al., 2010). Denoising, chimera detection and operational 
taxonomic unit (OTU) grouping at 97% similarity were performed using USEARCH v7 
(Edgar et al., 2010). OTU sequences were aligned using PyNAST and the SILVA SSURef 
database release 119 was used to determine taxonomy (Quast et al., 2013). Alpha and beta 
diversities were calculated using QIIME. Principal coordinate analysis (PCoA) plots were 
used to visualise differences in beta diversity based on UniFrac distances using EMPeror 
v0.9.3-dev (Vázquez-Baeza et al., 2013). 
1H NMR-Based Metabolomics  
Fecal water samples were subjected to one dimensional proton nuclear magnetic resonance 
(1H NMR) spectroscopy by preparing a mixture of 90% (v/v) sample and 10% (v/v) internal 
standard, which was used as a chemical shape indicator during metabolite quantification. The 
internal standard used was 5 mM 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS) in 99.9% 
D2O and 0.2% (w/v) NaN3. The sample mixture was transferred into 3 mm NMR tubes 
(Wilmad LabGlass, NJ, USA), and inserted into a Bruker Avance III 600.00 MHz 
spectrometer, equipped with a cryogenically-cooled triple resonance probe (TCI 600). 
Samples were scanned using a METNOESY pulse sequence, which is the first increment of a 
1D-NOESY (1 s relaxation delay, 0.1 s mixing time and 4 s acquisition time). NMR spectra 
were processed using Chenomx NMR Suite 8.0 (Chenomx Inc., AB, Canada), which allowed 
for manual phase and baseline corrections. Metabolite assignment in this program was 
performed by matching compound signatures in the software database to peaks in the sample 
spectra. Concentrations were determined using the known DSS concentrations as a reference. 
Sample pH measurements were obtained after spectrum acquisition using WhatmanTM pH 
indicator dip strips. 
 
 Statistical analysis  
‘R’ statistical software package (version 3.2.4) was used for statistical analysis and a number 
of software packages were installed including vegan, ape, car, ggplot, rgl and ade4. Statistical 
significance in alpha diversity measures was assessed for Chao1, Shannon and Simpson 
diversity indices and observed species. Alpha diversity measures were calculated by using the 
phylogenetic diversity and observed species present in the dataset. Species richness, as 
measured by Chao 1 diversity index, can be described as a quantification measurement, 
calculating the number of different species present in a community, omitting the abundance 
of each species. In contrast, the Shannon and Simpson diversity indices were used to 
determine species diversity and eveness of the microbial dataset, taking into account the 
relative abundance of each species present in a community. To assess beta-diversity, bray-
curtis distance matrices were generated on ‘R’ using the adonis function. Beta-diversity, 
defined as “the extent of change in community composition, or degree of community 
differentiation” (Whittaker, R.H. 1960), was visualized using PCoA. A non-parametric 
Kruskal-wallis test was used to determine statistical significance in the relative abundance of 
microbial taxa between the control and HIE treatment group. Statistical significance was 
accepted at p<0.05, with adjusted measures. A heatmap was also generated using Euclidean 
distance matrices on ‘R’ to compare microbial composition between groups. Clustering was 
performed with the hclust function in the R package gplots. Statistical analysis of 1H-NMR 
data was carried out using MetaboAnalyst 3.0 (Xia et al., 2016). Concentrations of metabolic 
compounds were normalised using a log transformation before performing statistical analysis. 
To determine whether the microbial dataset correlated with the metabolic data, co-inertia 
analysis was carried out using the ade4 package in ‘R’, using the Monte-Carlo test to generate 
an RV coefficient.  
RESULTS 
16S Microbial Composition  
Diversity measures 
During the course of this study a total of 17 faecal samples were collected from infants at 2 
years of age and subjected to 16S rRNA analysis. Multiple alpha diversity measures were 
calculated (see supplementary material figure1). Phylotype richness was measured using the 
Chao 1 diversity index, while both species richness and evenness of the microbial dataset 
were measured using the Shannon and Simpson diversity indices. No significant differences 
were found using the Chao 1 diversity index, however the Shannon and Simpson diversity 
indices were found to be significantly higher in the control group (p = 0.038), compared to 
the HIE treated group. To assess whether there was any significant difference in beta-
diversity between the two groups, a bray-curtis distance matrix was calculated and no 
significant difference was found (Pr(>F) = 0.122, see supplementary figure 2).  
Relative abundance of microbial taxa 
The relative abundance of phyla present in both groups was determined from the rarefied 
dataset and compared for statistical significance (see figure1, 2 & 3, supplementary table 1). 
At phylum level, Firmicutes was found to be the dominant phylum in both groups, however 
at family level the abundance of Lachnospiriaceae was found to be significantly higher in the 
HIE treated group (52.22%), compared to the control group (36.38%) (p =0.0172). At genus 
level this result corresponded with a significantly higher abundance of 
Lachnospiriaceae_Incertae.Sedis in the HIE treated group (11.73%), compared to the control 
(6.98%) (p = 0.035)  Indeed, Bacteroidetes was found to be significantly higher in the control 
group (8.65%), compared to the HIE treated group (2.30%) (p= 0.004), corresponding with 
significantly higher levels of Bacteroides at genus level in the control group (6.48%), 
compared to the HIE treated group (0.86%) (p = 0.002). Indeed, at genus level, high inter-
individual variation was observed between both groups. In the control group, Bifidobacterium 
and Blautia were present at an average relative abundance of 15.07% and 9.16% respectively, 
however the relative abundance of these genera were found to be inverted in the HIE treated 
group with an average relative abundance of Bifidobacterium at 9.16% and Blautia at 
15.49%. Lachnospira was also present in both the control and HIE treated group at an 
average relative abundance of 10.09% and 15.53% respectively. Interestingly, for two infants 
in the HIE treated group, Akkermansia was found to be quite high, with a relative abundance 
of 20.82% and 27.15% (see figure 3). Hierarchical clustering of samples, based on their 
relative microbial compositions, indicated that there were differences between the groups (see 
figure 4).  
Metabolomic Data 
Multivariate analysis was performed after sample normalisation using both principal 
coordinate analysis (PCA) and the partial least squared discriminative analysis (PLS-DA) in 
MetaboAnalyst3.0. PCA analysis revealed no clear separation between the control and HIE 
treated group in either 2D or 3D scores plots (see supplementary figure 4A and 4B). 
Subsequent PLS-DA was performed and found an initial separation between the two groups 
based on observations in the 2D and 3D scores plots (see supplementary figure 5A and 5B), 
however permutational analysis revealed no significance in separation distance after 100 
permutations ( p= 0.786 (786/1000). A PLS-DA variable importance measure was calculated 
using the weighted sum of the PLS-regression coefficients for the top 15 features (see 
supplementary figure 5C). Univariate analysis was also performed using a simple t-test (p 
<0.05) and found no significant features between the control group, compared to the HIE 
treated group.  Finally, a heatmap generated using Euclidean distance matrices on 
MetaboAnalyst3.0 indicated that there were no differences between the control and HIE 
treated group based on metabolic profile. This hierarchal clustering of samples highlighted 
high amounts of acetate across all samples in both groups, as well as low amounts of p-cresol, 
choline and formate (see figure 5).  
Co-inertia analysis between 16S compositional sequencing data and 1NMR metabolomics 
data found no correlation between the two sample types (see supplementary figure 3, p = 
0.13, Rv = 0.525) 
Discussion 
Microbial diversity and associated metabolic profiles have been extensively studied to 
investigate shifts or alterations in the gastrointestinal tract (GIT). For this study a total of 17 
faecal samples were examined in children at 2 years of age to answer one question; would 
TBC treatment in patients with HIE at birth have an effect on the gut microbiota and faecal 
metabolic profile in later life? Indeed it has been suggested that asphyxia and hypoxic-
ischemic injury may be the cause in some particular cases of necrotising entercolitis (NEC) 
(Young et al., 2011) (Torrazza and Neu, 2013). Thus, it is reasonable to suggest that this type 
of treatment at birth could impact the development of the gut microbiome.  
Findings from this study suggest that TBC in treating HIE at birth had no significant effect on 
the gut microbial composition or metabolic profile of infants at 2 years of age. High inter-
individual variation was observed between the control and HIE treated group, however 
analysis of microbial diversity found a significant decrease in the alpha diversity of our HIE 
treated group, suggesting that TBC may affect microbial richness in later life. In addition, a 
significant decrease in the relative abundance of Bacteroides was found in our HIE treated 
group, with an increased relative abundance of Lachnospiriaceae. This decreased abundance 
in Bacteroides may indeed have an impact on health outcomes in later life, with previous 
studies suggesting that a decreased abundance in Bacteroidetes is associated with an 
increased risk of developing obesity in later life (Kalliomäki et al., 2008) (Ley et al., 2005).  
Although differences in beta-diversity were non-significant, hierarchical clustering of 
samples, based on their relative microbial compositions, indicated that there was separation 
between the groups (see figure 4).   
Metabolic profiling of faecal samples detected acetate as the most abundant compound 
present in samples across both groups (see figure 5). Indeed, concentrations of faecal acetate 
have previously been reported to be higher in breast fed infants compared to formula and 
mixed-fed infants (Kleesen et al., 1995) (Siigur et al., 1993). Production of acetate has also 
been found to be anti-inflammatory in the regulation of colonic T-reg cells (Smith et al., 
2013), whilst absorption of acetate in the colon has also been found to increase cholesterol 
synthesis (Wong et al., 2006). Overall, high inter-individual variation was observed in the 
metabolic profile in both the control and HIE treated group.  Metabolic compounds which 
correlated with  the increased abundance of acetate included pyruvate, glucose, 4-
aminobutyrate and 5-aminopentanoate (see supplementary figure 6). Microbial metabolism of 
essential amino acid substrates has been found to increase metabolic by-products, including 
short chain fatty acids (SCFAs), acetate and butyrate, and branched chain fatty acids 
(BCFAs), isobutyrate and isovalerate. Moreover, production of these particular microbial by-
products has been found to improve colonocyte health and mucosal immunity (Blachier et al., 
2007).  
Overall, results from this study suggest that there is no negative impact to the gut microbial 
development of infants subjected to TBC at birth, compared to a healthy full term infant 
group at 2 years of life. To our knowledge this is the first study to report the gut microbial 
composition and metabolic profile in infants exposed to this type TBC treatment at birth.   
A limitation to this study included the small sample size in each group, in addition to the time 
period in which the samples were collected. Faecal samples were collected at 2 years of life 
and thus a number of confounding factors must be considered. Firstly diet is a very important 
factor which can affect the faecal metabolome and microbiota profile after birth, in particular 
the effect of human breast milk (HBM) during the first year of life. A review by Fanos et al., 
2015 concluded that further studies are necessary to evaluate the HBM metabolome in a 
variety of infant cohorts, with particular emphasis on breast milk collected from mothers’ of 
full term and preterm infants. Indeed the metabolome of preterm HBM has been found to 
have increased concentrations of lactose in comparison to full term HBM (Marincola et al., 
2012). In addition, HBM can be classified as ‘Secretor’ or non-Secretor’ milk due to the 
presence or absence of fucosyltransferase genes (FUT2 or FUT3), which in turn effect the 
structure of milk glycans and alter the bifidobacterial communities present in the gut (Lewis 
et al., 2015). In terms of metabolic profile, a recent study found that breast feeding strongly 
influenced the faecal metabolome of infants where a significantly increased abundance of 
acetate was found in exclusively breast fed infants, in comparison to a non-breast fed infant 
group; independent of delivery mode, intrapartum antibiotics, age and sex (Bridgman et al., 
2017).  
Thus, limitations to this study include the lack of metabolomic information on HBM supplied 
to the infants, in addition to the fecal metabolic profile during the first year of life. However, 
a standardized approach was followed during recruitment of the study and each infant 
received HBM from mothers whom delivered full term at birth.  Previous studies have 
correlated the faecal metabolic and microbial profiles of healthy infants’ overtime and have 
provided findings which provide insight to the current dataset in this study. For example, a 
significantly increased abundance of acetic acid and bifidobacteria was found in one breast 
fed infant cohort (Liu et al., 2016), and a study by Del Chierico et al., 2015 found a low 
abundance of acetate and butyrate which correlated with an increased abundance of 
Proteobacteria in a small cohort of breast fed and formula fed infants during the first 30 days 
of life (Del Chierico et al., 2015).  Moreover, the INFANTMET study, from which the 
control group for this study were recruited, has described the microbiota profile in the full 
term infant cohort, of both caesarean delivered and spontaneous vaginally delivered infants, 
to be dominated by similar levels of Bifidobacterium (average of ~52%) and Bacteroides 
(average of ~12%) at 6 months of age (Hill et al., 2017), however at 2 year of age the 
abundance of these genera decrease to 15% and 6% respectively, in this small subset of 
infants. 
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Captions for Figures 
Figure 1. Percentage relative abundance of microbial taxa at phylum level. 
Figure 2. Percentage relative abundance of microbial taxa at family level. 
Figure 3. Percentage relative abundance of microbial taxa at genus level. 
Figure 4. Hierarchically clustered heat map showing correlations between the relative microbial 
compositions in each group (control = HPC, HIE treatment group = HP). Clustering was performed 
with the hclust function in the R package gplots. The color of each tile of the heat map indicates the 
strength of the correlation for a given genera. (blue = 2, light blue = 1, orange = 0, green = -1, yellow 
= -2) 
Figure 5. Heatmap of 1H-NMR faecal metabolomic data using Euclidean distance matrices on 
MetaboAnalyst 3.0 
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at birth  
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HP 1 
2 3 41+3 
Vac -
Vaginal 
Formula yes Hypotraemia 
HP 4 
3 4 36+2 
breech - 
Vaginal 
Breast Milk yes 
Left temporal  extradural haematoma associated 
overlying cephalhaematoma 
HP 8 1 3 38 SVD Breast Milk yes Severe perinatal asphyxia 
HP 11 5 7 40+6 Vac-Vaginal Breast Milk yes HIE Grade 2 - Moderate Neonatal Encephalopathy 
HP 17 3 6 41+3 Vac-Vaginal Breast Milk 
 
HIE Grade 2 - Moderate 
HP 18 4 5 41+6 CS Breast Milk yes HIE Grade 2 - Moderate 
HP 19 6 8 40+1 Vac-Vaginal Breast Milk yes HIE Grade 2 - Moderate 
HP 23 0 4 39+4 CS Breast Milk yes 
 
HP 14 
1 5 
39+5 
 
CS 
Breast Milk 
+ Formula 
yes HIE Grade 2 - Moderate  
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HPC 117 
9 10 
39+2 
 
CS Breast Milk yes 
 
HPC 54 
9 9 
39+1 
 
SVD Breast Milk no 
 
HPC 98 9 10 39+5 CS Breast Milk yes 
 
 Table 1. Patient information for both groups (HP = hypothermia treated, HPC = control).  
 
HPC 200 7 9  SVD Breast Milk no 
 
HPC 44 9 9 40+2 SVD Breast Milk yes 
 
HPC 42 
9 10 
38 
 
SVD Breast Milk yes 
 
HPC 82 
9 10 
39+1 
 
CS - 
Emergency 
Breast Milk unknown 
 
HPC 58 
9 9 
37+2 
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